The pharmaceutical industry invests in safety.

Read more

The wholesalers react fast and flexible.

Read more

The dispensing persons ensure quality.

Read more

Austria implements EU-Falsified Medicines Directive - Maximum Security for Patients

The Mission of AMVS

On behalf of AMVO AMVS GmbH runs a data repository which records all medicinal products supposed to prescription, that are placed on the Austrian market.

Each pack of a medicinal products can be clearly identified. This is to ensure that no falsified medicinal products can enter into the legal supply chain.

The EU falsified medicines directive foresees measures against the entering of falsified medicinal products into the legal supply chain.

These measures include the placing of safety features consisting of:

  • an unique identifier (2D datamatrix code)
  • a device against tampering of the outer package
Implementation of the EU Directive 2011/62
  • EU Directive published (2011)
  • Del. Regulation published (2016)
  • Foundation of AMVS (2017)
  • EU Directive implemented (09.02.2019)

From February 9th 2019 until including February 8th 2020 a stabilisation period of 12 months takes place to guarantee a smooth start and the security of supply with medicinal products. During this time period all people and organisations involved have the opportunity to obtain and to correct possible process or application errors as well as to stabilise the newly implemented processes. Details regarding the stabilisation period can be found in the information document on the stabilisation period.

Stabilization period
021 days left